United States· US:44911-0339_25ce4f34-9cb5-4af1-89de-f71ed9d71cea
CO Q 10
A ubidecarenone product containing ubidecarenone, registered in United States by Energique, Inc.. The same ATC class is registered in 6 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Ubidecarenone is registered in 6 of 19 countries.
Countries holding a registration under ATC C01EB09 (ubidecarenone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Ubidecarenone · ATC C01EB09
6 / 19 countries
- Denmark
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- UBIDECARENONE
- Manufacturer
- Energique, Inc.
- Country
- United States (US)
- ATC code
- C01EB09
- ATC class
- Ubidecarenone
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1144911-0339-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ubidecarenone in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Kingdom10-Q Co-Enzyme Q10 100mg capsulesTriOn Pharma Ltd
- NorwayBio-qinon Q10 goldPharma Nord Norge AS
- PolandKoenzym Q10 fortePrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Denmark · Bio-Qinon Q10
- Hungary · Myoqinon
- Italy · Decorenone, Ubimaior
- Latvia · Bio-Quinone Q10
- Poland · Koenzym Q10 Forte
- Portugal · Q10, Q10 Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2416b1d6-bd49-461d-8ad0-c0c80ff2bbee GET /v1/drugs/2416b1d6-bd49-461d-8ad0-c0c80ff2bbee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "30",
"substance": "UBIDECARENONE",
"productndc": "44911-0339",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "[hp_X]/mL",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about ubidecarenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.